Tech Company M&A Transactions

JDS Pharmaceuticals Acquisition

Headquartered in New York, JDS Pharmaceuticals was bought by Noven Pharmaceuticals. Deal value was $125 million.

Transaction Overview

Announced On
7/10/2007
Transaction Type
M&A
Amount
$125,000,000
M&A Terms
The transaction is valued at approximately $125 million cash at closing plus the assumption of approximately $10 million in net liabilities.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
405 Lexington Avenue 59th Floor
New York, NY 10174
USA
Email Address
Not Recorded
Overview
JDS Pharmaceuticals is a specialty pharmaceutical company dedicated to improving the lives of people suffering from psychiatric illness.
Profile
JDS Pharmaceuticals LinkedIn Company Profile
Social Media
JDS Pharmaceuticals Company Twitter Account
Company News
JDS Pharmaceuticals News
Facebook
JDS Pharmaceuticals on Facebook
YouTube
JDS Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Phillip Satow
  Phillip Satow LinkedIn Profile  Phillip Satow Twitter Account  Phillip Satow News  Phillip Satow on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/10/2007: Appriss venture capital transaction
Next: 7/10/2007: National Banana venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary